Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lanier

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|June 15, 2007
Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonistsMarion C Lanier, Miklos Feher, Neil J Ashweek, et al.
Journal of the American Optometric Association|November 1, 1994
Multisite comparison of contact lens modalities. Daily disposable wear vs. conventional daily wear in successful contact lens wearersR J Nason, E L Boshnick, W M Cannon, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2007
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonistsMi Chen, Zhiqiang Guo, Marion C Lanier, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|October 1, 1996
A 3-year prospective study of the clinical performance of daily disposable contact lenses compared with frequent replacement and conventional daily wear contact lensesO D Solomon, M I Freeman, E L Boshnick, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.
Journal of Medicinal Chemistry|January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacyDeborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.
Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.
Journal of Medicinal Chemistry|October 25, 2008
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's diseaseXiaohu Zhang, John E Tellew, Zhiyong Luo, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|June 15, 2007
Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonistsMarion C Lanier, Miklos Feher, Neil J Ashweek, et al.
Journal of the American Optometric Association|November 1, 1994
Multisite comparison of contact lens modalities. Daily disposable wear vs. conventional daily wear in successful contact lens wearersR J Nason, E L Boshnick, W M Cannon, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2007
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonistsMi Chen, Zhiqiang Guo, Marion C Lanier, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|October 1, 1996
A 3-year prospective study of the clinical performance of daily disposable contact lenses compared with frequent replacement and conventional daily wear contact lensesO D Solomon, M I Freeman, E L Boshnick, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.
Journal of Medicinal Chemistry|January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacyDeborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.
Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.
Journal of Medicinal Chemistry|October 25, 2008
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's diseaseXiaohu Zhang, John E Tellew, Zhiyong Luo, et al.
Pageof 10